DOSSIER · 13F Holders · Q2 2026Healthcare · Pharmaceutical Preparations
TAK
TAKEDA PHARMACEUTICAL CO LTD
395 institutions still hold TAKEDA PHARMACEUTICAL CO LTD as of Q2 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 874060205·Pharmaceutical Preparations·395 13F holders·last filed Jun 30, 2026
AI Holders Summary · Q2 2026
395 institutions reported TAK in Q2 2026. Capital Research Global Investors leads at 23.5% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 20
375 more holders available. Log in →